BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Erwinase® 10.000 IU/vial, powder for solution for injection: Information on temporary shortages

Active substance: Crisantaspase

The company Jazz Pharmaceuticals Germany GmbH is circulating information on the fact that over a period of 4 to 5 weeks there will be temporary shortages as regards new orders of Erwinase®.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 38KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK